Galectin-7 as a potential predictive marker of chemo- and/or radio-therapy resistance in oral squamous cell carcinoma.

Galectin-7 as a potential predictive marker of chemo- and/or radio-therapy resistance in oral squamous cell carcinoma.
复制标题

DOI:
10.1002/cam4.195
复制
发表时间:
2014-04
期刊:
影响因子:
4
通讯作者:
Omura, Ken
Omura, Ken
中科院分区:
医学3区
文献类型:
--
作者:
Matsukawa, Sho;Morita, Kei-ichi;Negishi, Ayako;Harada, Hiroyuki;Nakajima, Yusuke;Shimamoto, Hiroaki;Tomioka, Hirofumi;Tanaka, Kae;Ono, Masaya;Yamada, Tesshi;Omura, Ken

文献摘要

参考文献

被引文献

相似文献

晚期口腔鳞状细胞癌(OSCC)的治疗需要多模式方法的整合。本研究的目的是确定肿瘤敏感性的预测因素,术前放疗/化疗的口腔鳞癌,以使肿瘤学家确定最佳的治疗策略,而没有相关的不良反应。在这里,福尔马林固定石蜡包埋(FFPE)组织样本的蛋白质表达谱从18个OSCC患者,称为学习的情况下,谁接受术前化疗和/或放疗后手术进行了分析,定量蛋白质组学和验证免疫组化在68个测试的情况下,以及在18个学习的情况下。我们确定半乳糖凝集素-7作为化疗和/或放疗耐药的潜在预测标志物,在68例测试病例中,半乳糖凝集素-7预测评分(G7 PS)预测这种耐药的灵敏度和特异性分别为96.0%和39.5%。G7 PS预测耐药患者的5年累积疾病特异性生存率为75.2%,敏感预测患者的5年累积疾病特异性生存率为100%。在体外过表达半乳糖凝集素-7显着降低OSCC细胞系的细胞活力。因此,我们的研究结果表明,半乳糖凝集素-7是一个潜在的预测标记物的化疗和/或放疗耐药的口腔鳞癌患者。鉴定来自敏感或耐药患者的OSSC样品中差异表达的蛋白质。通过LC-MS处理样品并用2DICAL分析。
Treatment of advanced oral squamous cell carcinoma (OSCC) requires the integration of multimodal approaches. The aim of this study was to identify predictors of tumor sensitivity to preoperative radiotherapy/chemotherapy for OSCC in order to allow oncologists to determine optimum therapeutic strategies without the associated adverse effects. Here, the protein expression profiles of formalin-fixed paraffin-embedded (FFPE) tissue samples from 18 OSCC patients, termed learning cases, who received preoperative chemotherapy and/or radiotherapy followed by surgery were analyzed by quantitative proteomics and validated by immunohistochemistry in 68 test cases as well as in the 18 learning cases. We identified galectin-7 as a potential predictive marker of chemotherapy and/or radiotherapy resistance, and the sensitivity and specificity of the galectin-7 prediction score (G7PS) in predicting this resistance was of 96.0% and 39.5%, respectively, in the 68 test cases. The cumulative 5-year disease-specific survival rate was 75.2% in patients with resistant prediction using G7PS and 100% in patients with sensitive prediction. In vitro overexpression of galectin-7 significantly decreased cell viability in OSCC cell line. Therefore, our findings suggest that galectin-7 is a potential predictive marker of chemotherapy and/or radiotherapy resistance in patients with OSCC. Identification of proteins differentially expressed in OSSC samples from patients sensitive or resistant. The samples were processed by LC-MS and analyzed with 2DICAL.
DOI: 10.1371/journal.pmed.0040176
发表时间: 2007-05
期刊: PLoS medicine
影响因子: 15.8
作者:
Critchley-Thorne RJ;Yan N;Nacu S;Weber J;Holmes SP;Lee PP
通讯作者: Lee PP
DOI: 10.1158/0008-5472.can-04-0985
发表时间: 2004-08-15
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Ueda, S;Kuwabara, I;Liu, FT
通讯作者: Liu, FT
DOI: 10.1074/mcp.t500039-mcp200
发表时间: 2006-07-01
影响因子: 7
作者:
Ono, Masaya;Shitashige, Miki;Yamada, Tesshi
通讯作者: Yamada, Tesshi
DOI: 10.1158/0008-5472.can-06-3891
发表时间: 2007-03-15
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Demers, Melanie;Biron-Pain, Katherine;St-Pierre, Yves
通讯作者: St-Pierre, Yves
DOI: 10.1053/j.gastro.2008.01.014
发表时间: 2008-04-01
期刊: GASTROENTEROLOGY
影响因子: 29.4
作者:
Inagaki, Yutaka;Higashi, Kiyoshi;Okazaki, Isao
通讯作者: Okazaki, Isao